Patent: 6,368,845
✉ Email this page to a colleague
Summary for Patent: 6,368,845
Title: | Polypeptides having L-asparaginase activity |
Abstract: | Disclosed are polypeptides which originate from mammal, having L-asparaginase activity. The polypeptides are easily prepared by applying recombinant DNA techniques to DNAs encoding the polypeptides and they exert satisfactory effects in the treatment and/or the prevention for diseases caused by tumor cells dependent on L-asparagine, and cause no substantial serious side effects even when administered to humans in relatively-high dose. |
Inventor(s): | Ario; Takeshi (Okayama, JP), Taniai; Madoka (Okayama, JP), Yamamoto; Kozo (Okayama, JP), Kurimoto; Masashi (Okayama, JP) |
Assignee: | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo (JP) |
Application Number: | 09/635,705 |
Patent Claims: | see list of patent claims |
Details for Patent 6,368,845
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Try a Trial | 2016-06-07 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |